What does SurgiMère do?

SurgiMère is a specialist medical practice in Waterloo. Private Limited, started on 15 April 2016, 2 establishments.

What is the address of SurgiMère?

The registered office of SurgiMère is located at Avenue des Lucioles 22, 1410 Waterloo.

Is SurgiMère still active?

Yes. According to the CBE (29 September 2026) SurgiMère is active, legal situation “Normale toestand”, started on 15 April 2016.

Is SurgiMère registered on Peppol?

Yes, SurgiMère is registered on the Peppol network with ID 0208:0651967583.

What is the enterprise number of SurgiMère?

The enterprise number of SurgiMère is BE0651967583.

When was SurgiMère founded?

SurgiMère was founded on 15 April 2016.

Who are the directors of SurgiMère?

According to the 2025 annual accounts, the directors of SurgiMère are: Julie Bavay.

Is SurgiMère a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 15 April 2016; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account; 2 establishments in the CBE.

How much profit did SurgiMère make in 2025?

SurgiMère recorded a loss after taxes of € 8,607 in financial year 2025.

What is the revenue of SurgiMère?

As a small company, SurgiMère is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 21,707.

SurgiMère (Private Limited) - Waterloo - BE0651967583

Dossier SurgiMère, printed on 29 September 2026 from databakkes.be/en/0651967583/surgimere. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

SurgiMère from Waterloo, company number BE0651967583, closed financial year 2025 with a result of € -8,607 after tax. For that financial year SurgiMère recorded a gross margin of € 21,707 and equity of € 323,094. Compared with financial year 2024, the result moved from € 108,707 to € -8,607. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 27, 2026.

What it is worth Healthy

€ 323,094

▼ 3% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -8,607

▼ still € 108,707 profit in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 182,310

▼ 53% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € 304,494.

People and assets in 2025

Vehicles and equipment

€ 4,243

▲ € 3,738 vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 18 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 343,334

€ 19,023 is repaid this year. At this pace the long-term loan is gone in ≈ 18 years.

Owed to suppliers

€ 3,919

▼ 7% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 3,501

▼ 50% vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 148,082 Gross margin 2022: € 148,082 First fiscal year in the series	€ 123,885 Gross margin 2023: € 123,885 ▼ 16% vs 2022 (€ 148,082) Unfavourable step	€ 142,192 Gross margin 2024: € 142,192 ▲ 15% vs 2023 (€ 123,885) Favourable step	€ 21,707 Gross margin 2025: € 21,707 ▼ 85% vs 2024 (€ 142,192) Unfavourable step	▼ 85%
Profit after taxes	€ 113,422 Profit after taxes 2022: € 113,422 First fiscal year in the series	€ 94,154 Profit after taxes 2023: € 94,154 ▼ 17% vs 2022 (€ 113,422) Unfavourable step	€ 108,707 Profit after taxes 2024: € 108,707 ▲ 15% vs 2023 (€ 94,154) Favourable step	€ -8,607 Profit after taxes 2025: € -8,607 ▼ € 117,315 vs 2024 (€ 108,707) Unfavourable step	▼ € 117,315
Equity	€ 379,894 Equity 2022: € 379,894 First fiscal year in the series	€ 331,701 Equity 2023: € 331,701 ▼ 13% vs 2022 (€ 379,894) Unfavourable step	€ 331,701 Equity 2024: € 331,701 Unchanged (€ 331,701) Unchanged	€ 323,094 Equity 2025: € 323,094 ▼ 3% vs 2024 (€ 331,701) Unfavourable step	▼ 3%
Total debts	€ 139,443 Total debts 2022: € 139,443 First fiscal year in the series	€ 164,780 Total debts 2023: € 164,780 ▲ 18% vs 2022 (€ 139,443) Unfavourable step	€ 120,470 Total debts 2024: € 120,470 ▼ 27% vs 2023 (€ 164,780) Favourable step	€ 353,103 Total debts 2025: € 353,103 ▲ 193% vs 2024 (€ 120,470) Unfavourable step	▲ 193%
Cash	€ 470,126 Cash 2022: € 470,126 First fiscal year in the series	€ 415,992 Cash 2023: € 415,992 ▼ 12% vs 2022 (€ 470,126) Unfavourable step	€ 388,214 Cash 2024: € 388,214 ▼ 7% vs 2023 (€ 415,992) Unfavourable step	€ 182,310 Cash 2025: € 182,310 ▼ 53% vs 2024 (€ 388,214) Unfavourable step	▼ 53%
Land & buildings	-	-	-	€ 390,344 Land & buildings 2025: € 390,344 First fiscal year in the series
Retained profit	€ 361,294 Retained profit 2022: € 361,294 First fiscal year in the series	€ 313,101 Retained profit 2023: € 313,101 ▼ 13% vs 2022 (€ 361,294) Unfavourable step	€ 313,101 Retained profit 2024: € 313,101 Unchanged (€ 313,101) Unchanged	€ 304,494 Retained profit 2025: € 304,494 ▼ 3% vs 2024 (€ 313,101) Unfavourable step	▼ 3%
Dividend	€ 113,422 Dividend 2022: € 113,422 First fiscal year in the series	€ 142,347 Dividend 2023: € 142,347 ▲ 26% vs 2022 (€ 113,422) Unchanged	€ 108,707 Dividend 2024: € 108,707 ▼ 24% vs 2023 (€ 142,347) Unchanged	€ 0 Dividend 2025: € 0 ▼ 100% vs 2024 (€ 108,707) Unchanged	▼ 100%
Bank debt	€ 16,139 Bank debt 2022: € 16,139 First fiscal year in the series	€ 16,306 Bank debt 2023: € 16,306 ▲ 1% vs 2022 (€ 16,139) Unfavourable step	€ 0 Bank debt 2024: € 0 ▼ 100% vs 2023 (€ 16,306) Favourable step	€ 343,334 Bank debt 2025: € 343,334 Unchanged (€ 0) Unfavourable step
Balance sheet total	€ 519,337 Balance sheet total 2022: € 519,337 First fiscal year in the series	€ 496,482 Balance sheet total 2023: € 496,482 ▼ 4% vs 2022 (€ 519,337) Unchanged	€ 452,171 Balance sheet total 2024: € 452,171 ▼ 9% vs 2023 (€ 496,482) Unchanged	€ 676,197 Balance sheet total 2025: € 676,197 ▲ 50% vs 2024 (€ 452,171) Unchanged	▲ 50%

Key figures of SurgiMère, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to SurgiMère?

What happened at SurgiMère in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 27, 2026 New annual accounts for financial year 2025: loss of € 8,607 (▼ € 117,315 vs 2024). filed late Source: NBB ↗
Jun 1, 2025 New establishment in Waterloo. KBO
Apr 15, 2016 New establishment in Waterloo. KBO
2016 Julie Bavay became a director. NBB
Apr 15, 2016 Start of the company according to the CBE. KBO

In short

From € 113,422 profit in 2022 to € 8,607 loss in 2025.

Paid € 89,465 in corporate taxes since 2022.

Best year ever: 2022, with € 113,422 profit.

Paid out € 364,477 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at SurgiMère? We notify you, reason included.

Follow SurgiMère

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Julie Bavay

SurgiMère

Behind SurgiMère is Julie Bavay.

See the full network in the app

Directors

According to the 2025 annual accounts

Julie Bavay

Director

since 2016

Establishments

Establishment units

Physical locations of this company

Registered office

Avenue des Lucioles 22

1410 Waterloo

2.374.708.963

Chaussée Bara 211

1410 Waterloo

Active since 1 June 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0651.967.583
VAT number: BE 0651.967.583
Registered office: Avenue des Lucioles 22, 1410 Waterloo
Names & denominations: SurgiMère
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 15 April 2016
Peppol: Active · Active since 19 May 2026
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗